Syncom Formulations (India) Limited

NSEI:SYNCOMF Stock Report

Market Cap: ₹13.4b

Syncom Formulations (India) Management

Management criteria checks 2/4

Syncom Formulations (India)'s CEO is Vijay Bankda, appointed in Dec 2004, has a tenure of 21.42 years. total yearly compensation is ₹6.49M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 11.77% of the company’s shares, worth ₹1.58B. The average tenure of the management team and the board of directors is 0.8 years and 3.3 years respectively.

Key information

Vijay Bankda

Chief executive officer

₹6.5m

Total compensation

CEO salary percentage100.00%
CEO tenure21.4yrs
CEO ownership11.8%
Management average tenureless than a year
Board average tenure3.3yrs

Recent management updates

Recent updates

Analysis Article Feb 02

Here's Why We Think Syncom Formulations (India) (NSE:SYNCOMF) Is Well Worth Watching

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article May 19

Syncom Formulations (India) Limited's (NSE:SYNCOMF) Business Is Trailing The Market But Its Shares Aren't

When close to half the companies in India have price-to-earnings ratios (or "P/E's") below 27x, you may consider Syncom...
Analysis Article Mar 08

Should You Be Adding Syncom Formulations (India) (NSE:SYNCOMF) To Your Watchlist Today?

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Analysis Article Jan 11

Does Syncom Formulations (India) (NSE:SYNCOMF) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article Dec 10

Getting In Cheap On Syncom Formulations (India) Limited (NSE:SYNCOMF) Is Unlikely

With a price-to-earnings (or "P/E") ratio of 67x Syncom Formulations (India) Limited ( NSE:SYNCOMF ) may be sending...
Analysis Article Aug 30

Syncom Formulations (India) Limited's (NSE:SYNCOMF) 27% Price Boost Is Out Of Tune With Earnings

Syncom Formulations (India) Limited ( NSE:SYNCOMF ) shares have continued their recent momentum with a 27% gain in the...
Analysis Article Jul 16

Syncom Formulations (India) Limited's (NSE:SYNCOMF) 27% Price Boost Is Out Of Tune With Earnings

Syncom Formulations (India) Limited ( NSE:SYNCOMF ) shareholders have had their patience rewarded with a 27% share...
Analysis Article Mar 21

Some Syncom Formulations (India) Limited (NSE:SYNCOMF) Shareholders Look For Exit As Shares Take 28% Pounding

Syncom Formulations (India) Limited ( NSE:SYNCOMF ) shares have had a horrible month, losing 28% after a relatively...
Analysis Article Dec 29

Syncom Formulations (India) Limited's (NSE:SYNCOMF) 27% Price Boost Is Out Of Tune With Earnings

Despite an already strong run, Syncom Formulations (India) Limited ( NSE:SYNCOMF ) shares have been powering on, with a...
Analysis Article Dec 27

Syncom Formulations (India) Limited's (NSE:SYNCOMF) Shares Climb 26% But Its Business Is Yet to Catch Up

Syncom Formulations (India) Limited ( NSE:SYNCOMF ) shareholders would be excited to see that the share price has had a...

CEO Compensation Analysis

How has Vijay Bankda's remuneration changed compared to Syncom Formulations (India)'s earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025n/an/a

₹690m

Sep 30 2025n/an/a

₹631m

Jun 30 2025n/an/a

₹576m

Mar 31 2025₹6m₹6m

₹494m

Dec 31 2024n/an/a

₹391m

Sep 30 2024n/an/a

₹331m

Jun 30 2024n/an/a

₹286m

Mar 31 2024₹9m₹9m

₹253m

Dec 31 2023n/an/a

₹264m

Sep 30 2023n/an/a

₹235m

Jun 30 2023n/an/a

₹206m

Mar 31 2023₹5m₹5m

₹201m

Dec 31 2022n/an/a

₹164m

Sep 30 2022n/an/a

₹162m

Jun 30 2022n/an/a

₹183m

Mar 31 2022₹6m₹6m

₹198m

Dec 31 2021n/an/a

₹220m

Sep 30 2021n/an/a

₹280m

Jun 30 2021n/an/a

₹316m

Mar 31 2021₹6m₹6m

₹292m

Dec 31 2020n/an/a

₹257m

Sep 30 2020n/an/a

₹192m

Jun 30 2020n/an/a

₹143m

Mar 31 2020₹2m₹2m

₹143m

Compensation vs Market: Vijay's total compensation ($USD67.50K) is above average for companies of similar size in the Indian market ($USD42.29K).

Compensation vs Earnings: Vijay's compensation has been consistent with company performance over the past year.


CEO

Vijay Bankda (67 yo)

21.4yrs
Tenure
₹6,485,232
Compensation

Mr. Vijay Shankarlal Bankda, B. Com LLB, has been the Managing Director at Syncom Formulations India Ltd since December 2004. Mr. Bankda began his career in 1976 and has a valuable experience of more than...


Leadership Team

NamePositionTenureCompensationOwnership
Ankit Bankda
Executive Chairmanless than a year₹2.81m4.99%
₹ 669.1m
Vijay Bankda
MD and Executive & Non Independent Director21.4yrs₹6.49m11.77%
₹ 1.6b
Vaishali Agrawal
Company Secretary & Compliance Officer3yrs₹452.00kno data
Rakesh Srivastava
Chief Marketing Officerno data₹2.54mno data
Kedarmal Bankda
Whole-Time Directorless than a year₹11.78m23.72%
₹ 3.2b
Rahul Bankda
CFO & President of Domestic Marketingless than a yearno data0.018%
₹ 2.4m
Payal Bankda
Vice President of Human Resourcesno data₹2.52mno data
Ankur Bankda
President of Export Marketingno datano data0.0068%
₹ 912.1k
0.8yrs
Average Tenure
45yo
Average Age

Experienced Management: SYNCOMF's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Ankit Bankda
Executive Chairmanless than a year₹2.81m4.99%
₹ 669.1m
Vijay Bankda
MD and Executive & Non Independent Director26.4yrs₹6.49m11.77%
₹ 1.6b
Kedarmal Bankda
Whole-Time Director34.1yrs₹11.78m23.72%
₹ 3.2b
Ruchi Jindal
Non-Executive Independent Woman Director3.9yrs₹25.00kno data
Ritesh Lunkad
Non-Executive Independent Director2.8yrs₹25.00kno data
Ankit Jain
Non-Executive Independent Director2.8yrs₹25.00kno data
3.3yrs
Average Tenure
44.5yo
Average Age

Experienced Board: SYNCOMF's board of directors are considered experienced (3.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/22 15:53
End of Day Share Price 2026/05/22 00:00
Earnings2025/12/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Syncom Formulations (India) Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.